BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.)  



New York City  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
Transparency Life Sciences To Conduct Sarcoidosis Trial For Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) ' Kiacta™ Using Crowdsourcing And Telemonitoring 9/19/2014 8:01:00 AM
Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) And BELLUS Health Announce Completion Of Enrollment In The Phase III Confirmatory Study of Kiacta™ For The Treatment Of AA Amyloidosis 5/28/2014 9:18:38 AM
Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) And BELLUS Health Announce Engagement Of Financial Advisor To Explore Sale Of KIACTA™, An Experimental Drug In Phase 3 Development For The Treatment Of AA Amyloidosis 5/7/2014 10:36:07 AM
Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) And BELLUS Health Announce Licence Agreement With Mount Sinai For KIACTATM In Sarcoidosis 5/2/2014 11:04:51 AM
Celtic Therapeutics Rebrands as Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) 3/11/2013 10:57:34 AM
Celtic Therapeutics Announces the Appointment of New Partner 10/29/2012 6:58:58 AM
Celtic Therapeutics Pledges $50 Million to Establish ADC Therapeutics, New Company Will Develop Antibody-Drug Conjugates 3/26/2012 7:29:25 AM
Resolvyx Pharmaceuticals, Inc. and Celtic Therapeutics Enter Final Agreement in Ophthalmology 1/10/2011 6:23:25 AM
Resolvyx Pharmaceuticals, Inc. and Celtic Therapeutics Ink Dry Eye Deal 10/26/2010 7:58:47 AM
Celtic Therapeutics and Spirogen Limited Release: Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer 9/15/2010 12:04:50 PM
12